Specific codes in ICD-10 are unique alphanumeric designations used to identify and categorize diseases, disorders, and conditions. They consist of 3-5 characters, including both letters and numbers, that provide a high level of detail and specificity.
| Language | Translation |
|---|---|
English
|
Paraplegia and tetraplegia |
French
|
Paraplégie et tétraplégie |
| Level | Code | Title | |
|---|---|---|---|
| 1 | VI | Diseases of the nervous system | |
| 2 | G80-G83 | Cerebral palsy and other paralytic syndromes | |
| 3 | G82 | Paraplegia and tetraplegia |
| Code | Title | |
|---|---|---|
| G82.0 | Flaccid paraplegia | |
| G82.1 | Spastic paraplegia | |
| G82.2 | Paraplegia, unspecified | |
| G82.3 | Flaccid tetraplegia | |
| G82.4 | Spastic tetraplegia | |
| G82.5 | Tetraplegia, unspecified |
| Active Ingredient | Description | |
|---|---|---|
| Tetrabenazine |
Tetrabenazine is a synthetic derivative of benzylquinolizine that causes depletion of dopamine and other monoamines in the central nervous system. The precise mechanism by which tetrabenazine exerts its effects is unknown, but is believed to be related to its effect as a reversible depletor of monoamines (such as dopamine, serotonin, norepinephrine, and histamine) from nerve terminals. Neurotransmitter depletion by a single dose of tetrabenazine is reversible and lasts only a few hours. |
